跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
EVICEL
Authorized
STANDARD
EVICEL
OMRIX BIOPHARMACEUTICALS LTD
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
51a9a137a16b4dda
Company
OMRIX BIOPHARMACEUTICALS LTD
Type
Standard
Approval Details
Approval Id
51a9a137a16b4dda
Drug Approval Canada Name
EVICEL
Product Name
EVICEL
Status
Cancelled Post Market
Status Date
2023-06-06
Original Market Date
2011-03-01
Din
02348497
Drug Class
Human
Dosage Form
Solution , Kit
Route Of Administration
Topical
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BC30 COMBINATIONS
Atc Name
b 02 bc 30
Aig Number
0252708001
Company Name
OMRIX BIOPHARMACEUTICALS LTD
Company Address
Mda Blood Bank, Sheba Hospital, Ramat-Gan, Kiryat Ono, Tel-Aviv, Israel, 5510801
Company Detail Path
/organization/omrix-biopharmaceuticals-ltd
Company Information
Pharmaceutical Company Name
OMRIX BIOPHARMACEUTICALS LTD
Country Name
Israel
Province Name
Central District
City Name
ramat gan,central district,country_il
Address
MDA Blood Serv.Sheba Hospital
Active Ingredients
FIBRINOGEN (HUMAN)
90 MG / ML
THROMBIN (HUMAN)
1200 UNIT / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
51a9a137a16b4dda
Type
Standard
Back to Health Canada Approvals
EVICEL - Health Canada Drug Approval Details